Department of Infectious Diseases
Address: | Jihlavská 340/20, 625 00 Brno, Pavilion B |
---|
Phone: | +420 532 23 2265 |
---|---|
E-mail: |
Total number of publications: 16
Articles
-
A perspective on genetic and polygenic risk scores - advances and limitations and overview of associated tools
Briefings in Bioinformatics, year: 2024, volume: 25, edition: 3, DOI
-
Autoantibodies neutralizing type I IFNs underlie severe tick-borne encephalitis in ∼10% of patients
JOURNAL OF EXPERIMENTAL MEDICINE, year: 2024, volume: 221, edition: 10, DOI
-
Co je nového v infektologii?
Vnitřní lékařství, year: 2024, volume: 70, edition: 2, DOI
-
Doporučený postup diagnostiky a léčby chronické hepatitidy D Datum vydání doporučení: 2023
Klinicka Mikrobiologie a Infekcni Lekarstvi, year: 2024, volume: 29, edition: 3 (Suppl.)
-
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023–January 2024
Influenza and Other Respiratory Viruses, year: 2024, volume: 18, edition: e13360, DOI
-
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
EUROSURVEILLANCE, year: 2024, volume: 29, edition: 3, DOI
-
Factors affecting mortality in COVID-19-associated pulmonary aspergillosis: An international ID-IRI study
Heliyon, year: 2024, volume: 10, edition: 14, DOI
-
Hepatitida C – možné průběhy onemocnění, význam terapie a dopady neléčené infekce
Farmakoterapie, year: 2024, volume: 20, edition: 4
-
Chřipka - aktuální klinická praxe
Geriatrie a gerontologie, year: 2024, volume: 2024, edition: 13 (2)
-
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024
EUROSURVEILLANCE, year: 2024, volume: 29, edition: 8, DOI